Latest News about SRPT
Recent news which mentions SRPT
   Bumble (BMBL) Stock Pops as Elliott Builds a Stake in Rival Match
   
  
  
  January 09, 2024
  From InvestorPlace
 
   Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
   
  
  
  January 09, 2024
  From InvestorPlace
 
   Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
   
  
  
  January 09, 2024
  From Benzinga
 
   2 Growth Stocks That Could Make You Richer in 2024 and Beyond
   
  
  
  January 09, 2024
  From Motley Fool
 
   5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
   
  
  
  January 08, 2024
  From Benzinga
 
   Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
   
  
  
  January 04, 2024
  From Benzinga
 
   3 Things About Sarepta Therapeutics Every Smart Investor Knows
   
  December 28, 2023
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  December 27, 2023
  From Benzinga
 
   Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
   
  
  
  December 22, 2023
  From Motley Fool
 
   1 Revolutionary Stock That Could Make You Richer in 2024 and Beyond
   
  December 17, 2023
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   Could Sarepta Therapeutics Stock Help You Become a Millionaire?
   
  December 09, 2023
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   My Take: 4 Strong Growth Stocks to Buy This Week
   
  
  
  December 08, 2023
  From Motley Fool
 
   3 Monster Stocks in the Making
   
  
  
  November 18, 2023
  From Motley Fool
 
   3 Stocks You’ll Regret Not Buying Soon: November 2023
   
  
  
  November 16, 2023
  From InvestorPlace
 
   Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
   
  
  
  November 15, 2023
  From Benzinga
 
   Jim Cramer Likes Founder Of AI Company, But Stock Is 'Losing A Fortune' And There's 'Too Much Hype There'
   
  
  
  November 15, 2023
  From Benzinga
 
   1 Gene Therapy Stock to Buy and Hold for the Long Haul
   
  November 08, 2023
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   Is It Time to Buy the Nasdaq's 4 Worst-Performing October Stocks?
   
  
  
  November 08, 2023
  From Motley Fool
 
   8 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 07, 2023
  From Benzinga
 
   Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
   
  November 02, 2023
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   Earnings Scheduled For November 1, 2023
   
  
  
  November 01, 2023
  From Benzinga
 From Benzinga
 
   Uphill Battle Ahead For Gene Therapy Player Sarepta, Analysts Lower Price Targets Following Duchenne Trial Miss
   
  October 31, 2023
  Tickers 
   SRPT
  
  
  From Benzinga
 
   Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  October 31, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's Intraday Session
   
  
  
  October 31, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.